Thanks, Franco.
comparisons want immaterial. otherwise XXXX, Before I unless I of quarter, in all currency begin, second And clarify quarter was to the second specified. refer foreign the to that
XX. all exclude Starting on comparisons revenue So, translation. Page currency
the quarter was Engineering the by XXX second Diagnostic decline of million. growth segment. driven in X% the a which expected XXXX, This and in increased Solutions For to the X% offset Biopharmaceutical revenue EUR segment,
vials, was the quarter revenue offset adversely of high-value represented of XX% affected solutions the which mix our solutions, in second which was expand EZ-fill XX% increase headwinds. X helped grew diversity and also product profit revenue quarter. in margin from high-value approximately favorable solutions. lower to This profit by Our mix The within gross in the
Gross high-value tempered total margin.
cost second First, the profit in segment the effect had gross the higher-than-anticipated on in margin Engineering the quarter. biggest
of vial to destocking, the lines. And from the phase causing impact the ramp-up our tied lastly, new our facilities. underutilization Second, vial of inefficiencies
important margin As a temporary headwinds gradually believe gross to in these profit headwinds, XX%. result to expect point temporary that that we these are will decreased we margins. subside. In a step-up is out of turn, and It
driven of Day, better solutions, our scale to during the and expansion mix assets of outlined and is Markets shift leverage we efficiencies. our As margin high-value expected benefit Capital operational the to be fixed by
For basis, on margin XX.X%. a the was XX.X%. profit lower to decline in second adjusted margin And to profit gross led quarter, an operating operating profit
second profit share On the EUR EUR and were XX.X and million, XX.X diluted diluted XX X.XX. EBITDA earnings share adjusted was X.XX. EUR of quarter were per million, totaled adjusted profit per adjusted million, was margin XXXX, earnings XX.X%. For net net an was EBITDA and Adjusted basis,
on to segment Moving XX. Page results
XXX increased revenue syringes. X% helped high-performance in while our quarter, solutions high-value of mostly XXXX, EUR growth solutions revenue to and BDS the XXX.X quarter diversity decreased by driven For from vials. to the X% drive to portfolio related second product containment revenue in to million, from XX% XXX.X decrease million. in from segment the EUR in X% EUR a grew The despite delivery growth million XX% other second Revenue
As expected, in benefited normalize to gross by high-value startup segment profit in impacted margins effects to Latin unfavorably and the of inventories continue be continue ongoing but as increase Fishers. and the margin, customer destocking solutions inefficiencies
that the revenue levels. expenses under productivity These these absorption the inefficiencies as reminder, a As of reflect volumes, target phases occurred are progressively natural the to and reach during grow inefficiencies early operations. of
improve impact that mature, this As will these and facilities we accordingly. decrease margins that believe will
year. basis profit margin compared point of segment represented in a prior gross second As This the quarter result, XXXX, the BDS XXX XX.X%. decrease to was
second margin to for same operating profit decreased year. XX.X% quarter, the the period XX.X% segment For last from the in BDS
XXXX, Engineering segment million. to second EUR from For quarter of the XX.X the XX% revenue decreased
process. certain noted, higher Frank to complex delays costs As have in customized on and highly projects led
margin market-leading in profit continued to It's the important mention X.X% As that quarter. our decreased profit interest a declined currently XX.X% operating strong for see we result, second to gross innovative to technologies. and margin
and a sheet actions growth next drive to improvements have segment the slide the review balance a turn Please to to for the the this necessary trajectory. we and that bring we With financial cash we can return to items. completion, performance of project believe flow improve ongoing, profitable
of support to continue carefully our manage growth capital We working business. to trade the
in through inventories XX to liquidity U.S. We are receivables. million, inventory in future of of additional from including generated on the products We and the our quarter, the operations, second our XXX.X have hand, the with XX.X adequate This that in months. our establishment trade priorities a million that and cash in available Italy, new baseline cash lines, to combination strategic ended financing. of operational our to we next levels by to mainly collections expected, equivalents customers due be debt net cash ability expected fund plants over partially credit cash and the and believe to our As of EUR assess EUR delivered and offset increased was quarter of quarters.
the In second quarter capital as of totaled cash million, expected, the activities of our expenditures million. XXXX, XX.X for net demand-driven quarter EUR operating XX.X ramp. As EUR totaled continue investments from second XXXX to
used During the quarter, the proceeds to initiatives XX.X efficiencies. flow of XX.X our Denmark cash of received as for resulted and second second in operational and Cash footprint equipment sale we intangible purchase of in plant property, of and optimize in in million. assets This building gain was our free EUR EUR million X negative of quarter. the part EUR a million the
XXXX. guidance on fiscal Lastly, for Slide updating XX, we are
Let to with me changes. approximately XXXX XX% which decrease with the now compared estimate XX% through revision. segment, Starting is walk you the year. for fiscal a main the the revenue We for reason last Engineering of
Turning to segment. BDS the
of the last current mid-single-digit with XXXX, segment. for fiscal remain the XXX continue consensus we EUR with we growth revenue compared to year, For estimate comfortable anticipate revenue and million
we in in X.XXX the million, range add EUR EUR the XXX expect X.XX when EUR all the billion. range X.XX billion So, of X.XX. and to to range XXXX, adjusted for now this EUR of EUR Adjusted fiscal diluted up in EPS to you million EBITDA XXX revenue of
right the to trajectory, Day. Capital place unchanged. consider We to and expand growth Markets return growth the we ingredients have margins as double-digit outlined construct long-term we our As remains our believe at in future
favorable particularly year, syringes, in Looking positive tailwind. segment, BDS is which solutions, high-value in a to in the momentum next we have
are This headwinds. On of tempered we the may our recovery is taking be factor, that currently segment. anticipate for the of by we the vials, side, the the EZ-fill the which in pace Engineering the bulk the corrective and includes and effect current other of largest growth actions timing
call provide We confident to will in in long-term on our we guidance Franco. our We Thank the and will back in will going but forward. you. our prospects continue growth update March. you remain to strategy I hand progress, formal